Skip to record

Executive record

Polly A. Murphy

Director at Celcuity Inc.

Follow record
More
Challenge a Claim

Alpha ID: alpha:person:polly-a-murphyVersion: public-0:d751713988987e9331980363e24189ceAs of: 2026-10-06

Not yet claimed8 published Claims4 sources
  • Director

Biography

Dr. Murphy served as Chief Business Officer at Avadel Pharmaceuticals plc from May 2024 through Alkermes plc's acquisition of Avadel in February 2026, and previously served as Chief Business Officer at UroGen Pharma, Inc. from August 2020 through May 2024. She held various leadership roles at Pfizer from 2008 to 2020, including Vice President and Head of Early Commercial Development for Pfizer Oncology. She received her D.V.M. and Ph.D. from Iowa State University and her M.B.A. from Nova Southeastern University.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.